Business

Lupin-Natco get USFDA nod to market generic hypertension drug

Lupin-Natco get USFDA nod to market generic hypertension drug The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts